HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 05, May 2018 – Dental health - The root to good health       » Drugs to watch 2018       » Dragonfly-inspired nano coating kills bacteria upon contact       » New compound improves stroke recovery in monkeys and mice       » Cancer stem cell therapy breakthrough       » Draft genome of tea plant sequenced      
NEWS CRUNCH
Collaboration is Cure for Better Global Health Outcomes, UK-India Experts Say
Bangalore India BIO 2016: Leaders in Life Sciences presented their views at the UK Trade & Investment (UKTI) India Making Tomorrow's Medicine.

Leaders in healthcare meet to discuss ways to boost improvements in medicine manufacturing

Healthcare and biotechnology companies should be focused on developing blockbuster drugs that benefit billions of patients, says world-leading healthcare experts, and this can only be done through collaboration and innovation they say.

Speaking at the opening day of the Bangalore India Bio, leaders in Life Sciences presented their views at the UK Trade & Investment (UKTI) India Making Tomorrow's Medicine.

Speaking at the event, Indian entrepreneur and Chairwoman of India's biggest bio-tech company, Biocon Limited, Dr Kiran Mazumdar Shaw, said in making the Medicines of Tomorrow, the endeavour should be to leverage innovation to develop therapies which are affordable and accessible.

"As global priorities shift from providing exclusive and expensive drugs to more affordable drugs to enhance access to greater patient populations, we need to focus on developing blockbuster drugs with a potential to benefit a billion patients," said Ms Shaw.

"A developing country like India needs to invest in an affordable innovation model that can help address the burgeoning healthcare challenges of India, where 80 percent of healthcare expenses are borne by the patients, in the absence of a universal healthcare program run by the Government."

"The UK, with its ecosystem of research institutes, innovative companies and a large scientific pool, has become an important destination for high-end innovation and research. As large numbers of Indian companies commit themselves to innovation, UK's innovation ecosystem can provide learning opportunities for these companies to develop new competencies through collaborative research and alliances and join hands in their pursuit of addressing unmet medical needs," she said.

The UK has the strongest overseas presence with more than 20 companies participating in the 16th edition of Bangalore India Bio. Deputy High Commissioner, Dominic McAllister, said the UK and India have built a legacy of collaboration in life sciences over recent years.

"Our role within the British Deputy High Commission in Bengaluru is to not only strengthen existing links, but also to explore new ways of working together. Making Tomorrow's Medicines in India using UK capabilities is aligned to Prime Minister Modi's vision of Make In India and is an example of GREAT for Collaboration an exciting campaign that inspires new partnerships between the UK and India.

The UK has a long track record of cost-effective and compliant medicines manufacturing from leading global companies. India has taken over from Italy as one of the leading supplier of manufacturing supply chains and is ideally positioned to be the hub of activity around Making Tomorrow's Medicine.

Jon Mowles, UKTI Life Science Sector Specialist, who is leading the British delegation, said that the UK has a rich heritage of life science discovery that has transformed scientific knowledge and continues to unlock clinical and commercial opportunities for many countries, including India.

"UK science is world-class, offering industry an opportunity to partner with globally recognised pioneers and innovators. Twenty-five percent of drugs in the UK are made in India and I am looking forward to meeting with Indian experts and discuss how we can Make Tomorrow's Medicine together," he said.

Interested parties can also visit and meet UKTI Investment Advisors at Bangalore Bio 2016 who can assist with collaboration opportunities with the UK.

More information about the UKTI participation in Bangalore India Bio 2016
https://www.eventbrite.co.uk/e/making-tomorrows-medicine-tickets-21338798922
https://www.eventbrite.co.uk/e/indo-uk-knowledge-series-for-start-ups-tickets-21370814682

Making Tomorrow's Medicine (MTM): UK Trade and Investment along with other UK government departments in their headquarters are working on a global campaign on supporting select countries in Making Tomorrow's Medicine that the world will need. This could be towards technology transfer for global vaccine design and development or process innovations towards sustainability in fuels in the pharma manufacturing industry. The UK has strengths in most. This also sits very well with the 'Make in India' campaign.

GREAT for Collaboration is an ambitious and exciting new campaign to showcase India-UK business collaboration. The campaign, launched by Prime Minister Modi and Prime Minister Cameron, will inspire new partnerships and encourage greater awareness of the scale of the UK's commitment to India. The overall objective is to increase business between the two countries. The campaign showcases and promotes collaborations of mutual benefit to India and the UK across a range of sectors, such as energy, healthcare, advanced manufacturing, financial services and infrastructure.

GREAT for Collaboration video https://www.youtube.com/watch?v=69pljBdULeg

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy